comparemela.com

Latest Breaking News On - Goldman sachs alternatives - Page 7 : comparemela.com

TORL secures $158m for oncology pipeline development

Clinical-stage biotechnology company TORL BioTherapeutics has announced the closure of an oversubscribed $158m Series B-2 financing round.

Mark-alles
Bristol-myers-squibb
Perceptive-xontogeny-venture-fund
Deep-track-capital
Perceptive-advisors
Goldman-sachs-alternatives
Moore-strategic-ventures
Vertex-ventures
Blue-owl-healthcare-opportunities
Avidity-partners

Grow Therapy Secures $88M To Expand Mental Health Services

Grow Therapy Secures $88M To Expand Mental Health Services
medcitynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medcitynews.com Daily Mail and Mail on Sunday newspapers.

New-york
United-states
American
Jake-cooper
Lauren-holiday
Anna-kendrick
Pat-grady
Dak-prescott
Lily-collins
Sequoia-capital
Grow-therapy
York-city-based-grow-therapy

Exclusive: Inside Wiz's acquisition of Gem Security

Exclusive: Inside Wiz's acquisition of Gem Security
fortune.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fortune.com Daily Mail and Mail on Sunday newspapers.

Israel
Paris
France-general
France
Sacramento
California
United-states
Madrid
Spain
Copenhagen
Køavn
Denmark

TORL BioTherapeutics Announces $158 Million Oversubscribed Series B-2 Financing to Advance the Clinical Development of its Novel Antibody-Drug Conjugate (ADC) Oncology Pipeline

$158M Series B-2 Financing led by Deep Track Capital, with new participation from leading global biotechnology investors including RA Capital Management,.

Dave-licata
Vince-ruiz
Ribociclib-kisqali
Mark-alles
Palbociclib-ibrance
Dennis-slamon
Perceptive-xontogeny-venture-fund
Slamon-research-laboratory
Bristol-myers-squibb
Division-of-hematology-oncology
Roth-zabel
Crandon-law

TORL BioTherapeutics Raises $158M in Series B-2 Financing

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Los-angeles
Dennis-slamon
Mark-alles
Perceptive-xontogeny-venture-fund
Bristol-myers-squibb
Division-of-hematology-oncology
Slamon-research-lab
David-geffen-school
Deep-track-capital
Perceptive-advisors
Avidity-partners
Goldman-sachs-alternatives

vimarsana © 2020. All Rights Reserved.